Indofarma Tbk. vs Reliance Sekuritas Indonesia Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Reliance Sekuritas Indonesia Tbk. trades at Rp560 (market cap 999B, 33.8K 24h volume). The key difference: Reliance Sekuritas Indonesia Tbk. is far larger — about 2.6× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | RELI | |
|---|---|---|
Market Cap | 390.51B | 999B |
Volume | — | 33.8K |
Lot | — | 338 |
Turnover | — | 18.78M |
Average Price | — | 555.58 |
Value | — | 18.78M |
Indicative Equilibrium Price | — | 560 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT. Reliance Securities (the company) was established under its original name of Istethmar Finas Securities on 22 Feb 1993 then changed to PT Ludlow Securities on 13 Sep 1999. According with Notaries deed on 28 March 2003 company's name changed to PT Reliance Securities. And the company's name changed to PT Reliance Securities Tbk on 19 May 2005 with amended the articles of association no 19 dated 14 April 2005.
Read more on RELI →